MARC S. HANOVER
Profile
First Name
: MARC
Middle Name
: S.
Last Name
: HANOVER
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
HAXEL M. AKER, HAZEL M. AKER, IGOR BILINSKY, PH.D., JAMES B. BREITMEYER, M.D., PH.D., MICHAEL G. CARTER, MICHAEL G. CARTER, M.D., CH.B., F.R.C.P., MICHAEL G. CARTER, M.D., CHB, FRCP, MAN CHO, JAMES T. DALTON, HENRY P. DOGGRELL, BARRINGTON J.A. FURR, J. KENNETH GLASS, DAVID F. HALE, FRANK HSU, M.D., J. R. HYDE, III, GUNNAR F. KAUFMANN, DANIEL KISNER, M.D., WILLIAM R. LARUE, XIN NAKANISHI, PH.D., GARRY A. NEIL, M.D., KENNETH S. ROBINSON, KENNETH S. ROBINSON, M.D., M.DIV., JASON SHACKELFORD, JASON T. SHACKELFORD, MITCHELL S. STEINER, CHARLES THEUER, RICHARD VINCENT, ROBERT WILLS, PH.D., ROBERT J. WILLS, PH.D., DIANE C. YOUNG, M.D.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-09-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-11-14
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-03-06
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-03-06
